Disciplined Growth Investors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-566,746
| Closed | -$782K | – | 67 |
|
|
2024
Q4 | $782K | Sell |
566,746
-199,562
| -26% | -$275K | 0.01% | 61 |
|
|
2024
Q3 | $797K | Sell |
766,308
-490,781
| -39% | -$510K | 0.02% | 63 |
|
|
2024
Q2 | $2.17M | Buy |
1,257,089
+1,152
| +0.1% | +$1.99K | 0.04% | 60 |
|
|
2024
Q1 | $3M | Buy |
1,255,937
+89,210
| +8% | +$213K | 0.05% | 59 |
|
|
2023
Q4 | $3.89M | Sell |
1,166,727
-16,899
| -1% | -$56.3K | 0.08% | 55 |
|
|
2023
Q3 | $4.43M | Buy |
1,183,626
+3,941
| +0.3% | +$14.7K | 0.11% | 56 |
|
|
2023
Q2 | $5.04M | Buy |
1,179,685
+14,173
| +1% | +$60.5K | 0.11% | 54 |
|
|
2023
Q1 | $7.97M | Buy |
1,165,512
+22,092
| +2% | +$151K | 0.2% | 52 |
|
|
2022
Q4 | $9.06M | Buy |
1,143,420
+11,324
| +1% | +$89.7K | 0.23% | 54 |
|
|
2022
Q3 | $10.9M | Buy |
1,132,096
+886,075
| +360% | +$8.51M | 0.3% | 53 |
|
|
2022
Q2 | $1.78M | Buy |
246,021
+1,100
| +0.4% | +$7.96K | 0.05% | 65 |
|
|
2022
Q1 | $3.16M | Buy |
244,921
+8,855
| +4% | +$114K | 0.07% | 66 |
|
|
2021
Q4 | $3.77M | Sell |
236,066
-218,358
| -48% | -$3.49M | 0.08% | 64 |
|
|
2021
Q3 | $7.3M | Hold |
454,424
| – | – | 0.14% | 63 |
|
|
2021
Q2 | $6.29M | Buy |
454,424
+45,581
| +11% | +$630K | 0.12% | 65 |
|
|
2021
Q1 | $5.97M | Sell |
408,843
-49,600
| -11% | -$725K | 0.12% | 63 |
|
|
2020
Q4 | $7.97M | Sell |
458,443
-13,771
| -3% | -$239K | 0.15% | 63 |
|
|
2020
Q3 | $8.66M | Buy |
+472,214
| New | +$8.66M | 0.2% | 60 |
|